Delayed, recurrent hypotonous maculopathy following aqueous suppressant therapy in pseudophakia.
Goela
A
A
University of Ottawa Eye Institute, Ottawa Hospital, Ont.
Damji
K F
KF
Daneshvar
H
H
Gilberg
S M
SM
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects*; D000959:Antihypertensive Agents / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D005260:Female; D015812:Glaucoma, Angle-Closure / Q000188:drug therapy / Q000209:etiology; D005902:Glaucoma, Open-Angle / Q000188:drug therapy / Q000209:etiology; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects*; D002040:Levobunolol / Q000009:adverse effects; D008266:Macula Lutea / Q000000981:diagnostic imaging / Q000473:pathology; D008875:Middle Aged; D015814:Ocular Hypotension / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy; D009883:Ophthalmic Solutions; D011239:Prednisolone / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000627:therapeutic use; D011355:Prodrugs / Q000008:administration & dosage / Q000627:therapeutic use; D019591:Pseudophakia / Q000150:complications*; D012008:Recurrence; D012164:Retinal Diseases / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy; D013449:Sulfonamides; D013876:Thiophenes; D014463:Ultrasonography
D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D009883:Ophthalmic Solutions; D011355:Prodrugs; D013449:Sulfonamides; D013876:Thiophenes; C009935:prednisolone acetate; C062765:dorzolamide; D011239:Prednisolone; D002040:Levobunolol